Viability of sham litigation suits on the line in AbbVie appeal
The award of $448 million in antitrust damages against the company in case brought by the Federal Trade Commission is also at stake.
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.